Anchor Investment Management’s Arcus Biosciences RCUS Stock Holding History

Anchor Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30	Closed	-$715	–	1087
2025 Q4	$715	Hold	30	–	–	﹤0.01%	1017
2025 Q3	$408	Hold	30	–	–	﹤0.01%	1040
2025 Q2	$244	Hold	30	–	–	﹤0.01%	1026
2025 Q1	$236	Hold	30	–	–	﹤0.01%	1022
2024 Q4	$447	Hold	30	–	–	﹤0.01%	1000
2024 Q3	$459	Hold	30	–	–	﹤0.01%	1021
2024 Q2	$457	Hold	30	–	–	﹤0.01%	973
2024 Q1	$566	Hold	30	–	–	﹤0.01%	1007
2023 Q4	$573	Hold	30	–	–	﹤0.01%	931
2023 Q3	$539	Hold	30	–	–	﹤0.01%	947
2023 Q2	$609	Hold	30	–	–	﹤0.01%	935
2023 Q1	$547	Hold	30	–	–	﹤0.01%	964
2022 Q4	$620	Hold	30	–	–	﹤0.01%	931
2022 Q3	$785	Hold	30	–	–	﹤0.01%	945
2022 Q2	$760	Hold	30	–	–	﹤0.01%	945
2022 Q1	$947	Buy	+30	New	+$1K	﹤0.01%	959

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Anchor Investment Management's RCUS Position: Q1 2026 in Review

Anchor Investment Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 30 shares — an estimated $715 sold.

Anchor Investment Management first reported a position in RCUS in Q1 2022 and held it in 16 quarters. The position peaked at $947 in Q1 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Anchor Investment Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
Anchor Investment Management sold 30 Arcus Biosciences shares in Q1 2026, an estimated $715.
Anchor Investment Management first reported a position in Arcus Biosciences in Q1 2022 and held it in 16 quarters.
Anchor Investment Management's Arcus Biosciences position peaked at $947 in Q1 2022.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.